Chu LF, Angst MS, Clark D: Opioid-induced hyperalgesia in humans: Molecular mechanisms and clinical considerations. Clin J Pain 2008;24:479.
Curran MP et al: Alvimopan. Drugs 2008;68:2011.
Dahan A et al: Sex-specific responses to opiates: Animal and human studies.
Anesth Analg 2008;107:83.
Davis MP, Walsh D: Methadone for relief of cancer pain: A review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer 2001;9:73.
Ferner RE, Daniels AM: Office-based treatment of opioid-dependent patients. N Engl J Med 2003;348:81.
Ferrante FM: Principles of opioid pharmacotherapy: Practical implications of basic mechanisms. J Pain Symptom Manage 1996;11:265.
Fields HL, Basbaum AI: Central nervous system mechanisms of pain modulation. In: Wall PD, Melzack R (editors): Textbook of Pain. Churchill Livingstone, 1999.
Fillingim RB, Gear RW: Sex differences in opioid analgesia: Clinical and experimental findings. Eur J Pain 2004;8:413.
Fischer BD, Carrigan KA, Dykstra LA: Effects of N-methyl-d-aspartate receptor antagonists on acute morphine-induced and l-methadone-induced antinociception in mice. J Pain 2005;6:425.
Goldman D, Barr CS: Restoring the addicted brain. N Engl J Med 2002;347:843.
Inui S: Nalfurafine hydrochloride for the treatment of pruritus. Expert Opin Pharmacother 2012;13:1507.
Joly V et al: Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 2005;103:147.
Julius D, Basbaum AI: Molecular mechanisms of nociception. Nature 2001;413:203.
Kalso E et al: No pain, no gain: Clinical excellence and scientific rigour—Lessons learned from IA morphine. Pain 2002;98:269.
Kharasch ED et al: Methadone pharmacogenetics: CYP2B6 polymorphisms determine plasma concentrations, clearance, and metabolism. Anesthesiology 2015;123:1142.
Kiefer BL: Opioids: First lessons from knockout mice. Trends Pharmacol Sci 1999;20:19.
Kim JA et al: Morphine-induced receptor endocytosis in a novel knockin mouse reduces tolerance and dependence. Curr Biol 2008;18:129.
Lai J et al: Pronociceptive actions of dynorphin via bradykinin receptors. Neurosci Lett 2008;437:175.
Lambert DG: The nociceptin/orphanin FQ receptor: A target with broad therapeutic potential. Nat Rev Drug Discov 2008;7:694.
Laughlin TM, Larson AA, Wilcox GL: Mechanisms of induction of persistent nociception by dynorphin. J Pharmacol Exp Ther 2001;299:6.